RbAp48 regulates cytoskeletal organization and morphology by increasing K-Ras activity and signaling through

Anna Scuto1, Hongling Zhang, Haiyan Zhao

  • 1Division of Molecular Medicine, City of Hope Beckman Research Institute, National Medical Center, Duarte, California, USA.

Cancer Research
|November 3, 2007
PubMed

Insights

RbAp48 protein influences cell shape and cytoskeleton organization by activating Ras signaling and mitogen-activated protein kinase (MAPK). Reducing RbAp48 levels restores normal cell structure and Ras activity.

Area of Science:

  • Cell Biology
  • Molecular Biology
  • Cancer Research

Background:

  • RbAp48 is a WD-40 protein known for its roles in chromatin metabolism and Ras signaling.
  • Its involvement in cytoskeletal organization was previously uncharacterized.

Purpose of the Study:

  • To investigate the novel function of RbAp48 in regulating cellular morphology and cytoskeletal organization.
  • To elucidate the molecular pathways, including Ras and MAPK signaling, involved in RbAp48-mediated cellular changes.

Main Methods:

  • Transfection of RbAp48 into Hs-578T breast cancer cells and RbAp48 knockdown using small interfering RNA.
  • Analysis of cell morphology, F-actin organization, and nuclear/cytoplasmic ratio.
  • Assessment of Ras and mitogen-activated protein kinase (MAPK) activity.
  • Pharmacologic inhibition of MAPK pathway.

Main Results:

  • Overexpression of RbAp48 in breast cancer cells caused reduced cell size, rounded shape, decreased protrusions, and disrupted F-actin organization.
  • RbAp48 overexpression activated MAPK and increased K-Ras activity, with K-Ras-GTP as the dominant isoform.
  • MAPK inhibition partially restored cytoskeletal organization, and RbAp48 knockdown reversed morphologic changes and normalized Ras/MAPK activity.

Conclusions:

  • RbAp48 plays a significant role in regulating cellular morphology and cytoskeletal organization.
  • This regulation is mediated through the activation of Ras signaling, specifically K-Ras, and subsequent signaling through MAPK.
  • RbAp48 represents a potential therapeutic target for modulating cell shape and cytoskeletal dynamics in cancer.

Related Concept Videos

MAPK Signaling Cascades01:07

MAPK Signaling Cascades

Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
The Ras Gene02:38

The Ras Gene

The Ras-gene-encoded proteins are regulators of signaling pathways controlling cell proliferation, differentiation, or cell survival. The Ras-gene family in humans constitutes three primary members—the HRas, NRas, and KRas. These genes code for four functionally distinct yet closely related proteins—the HRas, NRas, KRas4A, and KRas4B. The involvement of mutant Ras genes in human cancer was first discovered in 1982 and is among the most common causes of human tumorigenesis.
Ras is a superfamily...
Small GTPases - Ras and Rho01:24

Small GTPases - Ras and Rho

Ras and Rho are small monomeric GTPases that act downstream of receptor tyrosine kinase (RTK) and regulate various cellular processes. These GTPases switch between active and inactive states by binding to guanine nucleotides.
Three regulatory proteins control their activity:
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a rapamycin-insensitive companion...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
Cytoskeletal Coordination in Cell Migration01:32

Cytoskeletal Coordination in Cell Migration

A migrating cell changes its shape during the cyclic events of attachment and detachment from the substratum and repositions the cell organelles correspondingly. These complex events are orchestrated by the dynamic cytoskeletal network comprising actin filaments, intermediate filaments, and microtubules. Cytoskeletal crosstalk — the direct and indirect communication between the different components — is crucial for this coordination. Direct communication involves various linker proteins that...